Clinical recovery in first-episode psychosis

Schizophrenia Bulletin

Volumn 35, Issue 2, 2009, Pages 362-369

  Wunderink, Lex ^a   Sytema, Sjoerd ^a   Nienhuis, Fokko J ^a   Wiersma, Durk ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Disability; Duration of untreated psychosis; Remission; Schizophrenia; Social functioning

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 65349126667     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn143     Document Type: Article

References (43)

1. van Os J, Burns T, Cavallaro R, et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand. 2006;113:91-95.
2. Kraepelin E. Dementia Praecox and Paraphrenia. RB Barclay, trans-ed. Edinburgh, UK: ES Livingston; 1919.
3. Andreasen NC. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand. 2006;113:81.
4. Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15-and 25-year international follow-up study. Br J Psychiatry. 2001;178:506-517.
5. Hopper K, Harrison G, Janca A, Sartorius N. Recovery From Schizophrenia: An International Perspective. A Report From the WHO Collaborative Project, the International Study of Schizophrenia. Oxford University Press; 2007.
6. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151:1409-1416.
7. Andreasen NC, Carpenter WT, Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-449.
8. Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002;14:256-272.
9. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull. 2005; 31:723-734.
10. Strauss JS, Carpenter WT, Jr. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry. 1974;31:37-42.
11. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, I: methodology, study sample, and overall status 32 years later. Am J Psychiatry. 1987;144:718-726.
12. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A. The Vermont longitudinal study of persons with severe mental illness, II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry. 1987;144:727-735.
13. Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.J. Clin Psychiatry. 2007;68:654-661.
14. Wunderink L, Nienhuis FJ, Sytema S, Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull. 2007;33:792-796.
15. Department of Health and Human Services Achieving the Promise: Transforming Mental Health Care in America. Rock-ville, Md: Substance Abuse and Mental Health Services Administration; 2003.
16. Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull. 2006;32:432-442.
17. Resnick SG, Fontana A, Lehman AF, Rosenheck RA. An empirical conceptualization of the recovery orientation. Schizophr Res. 2005;75:119-128.
18. American Psychiatric Association. Position Statement on the Use of the Concept of Recovery. Washington, DC: American Psychiatric Association; 2005.
19. Davidson L, Schmutte T, Dinzeo T, Andres-Hyman R. Remission and recovery in schizophrenia: practitioner and patient perspectives. Schizophr Bull. 2008;34:5-8.
20. Wyatt RJ, Damiani LM, Henter ID. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. Br J Psychiatry Suppl. 1998;172:77-83.
21. Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry. 1995;52:173-188.
22. Gitlin M, Nuechterlein K, Subotnik KL, et al. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry. 2001; 158:1835-1842.
23. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
24. Link BG, Mesagno FP, Lubner ME, Dohrenwend BP. Problems in measuring role strains and social functioning in relation to psychological symptoms.J. Health Soc Behav. 1990; 31:354-369.
25. Mueser KT, Tarrier N. Handbook of Social Functioning in Schizophrenia. Boston, Mass: Allyn and Bacon; 1998.
26. Bellack AS, Green MF, Cook JA, et al. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull. 2007;33:805-822.
27. World Health Organisation. International Classification of Impairments, Disabilities and Handicaps. Geneva, Switzerland: World Health Organisation; 1980.
28. World Health Organisation. International Classification of Functioning, Disability and Health. Geneva, SwitzerlandWorld Health Organisation; 2001.
29. Kraaijkamp HJM. Difficult Roles. A study into the Reliability and Validity of the Groningen Social Disabilities Schedule in Psychiatric Patients. Department of Psychiatry, Groningen University: Groningen, The Netherlands; 1992.
30. Wiersma D, Jong Ad, Ormel J. The Groningen Social Disabilities Schedule: development, relationship with the ICIDH and psychometric properties. Int J Rehabilit Res. 1988;11: 213-224.
31. Wiersma D, de Jong A, Kraaijkamp HJM, Ormel J. GSDSII, The Groningen Social Disabilities Schedule, Second Version. Groningen, The Netherlands: Department of Psychiatry, Rijksuniversiteit Groningen; 1990.
32. Wiersma D. Role functioning as a component of quality of life in mental disorders. In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. West Sussex, England. 2nd ed. John Wiley & Sons; 2005. p. 45-56.
33. Schutzwohl M, Jarosz-Nowak J, Briscoe J, Szajowski K, Kal-lert T. Inter-rater reliability of the Brief Psychiatric Rating Scale and the Groningen Social Disabilities Schedule in a European multi-site randomized controlled trial on the effectiveness of acute psychiatric day hospitals. Int J Methods Psychiatr Res. 2003;12:197-207.
34. Liberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr Serv. 2005; 56:735-742.
35. Hafner H, Riecher-Rossler A, Hambrecht M, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209-223.
36. World Health Organisation. Schedules for Clinical Assessment in Neuropsychiatry. 2.1 ed. Geneva, Switzerland: World Health Organisation; 1992.
37. Wunderink A, Nienhuis FJ, Sytema S, Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr Scand. 2006;113:332-339.
38. O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res. 2000;9:121-124.
39. Liberman RP, Kopelowicz A. Recovery from schizophrenia: a challenge for the 21st century. Int Rev Psychiatry. 2002; 14:245-255.
40. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry. 1992;149: 1183-1188.
41. Lieberman J, Jody D, Geisler S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry. 1993;50:369-376.
42. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Crou-dace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975-983.
43. Hanssen MSS, Bijl RV, Vollebergh W, van Os J. Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders? Acta Psychiatr Scand. 2003;107:369-377.